It is a slideshare about the improvement of industrialization area in the department of Pharmaceuticals in Independent India

1. INDIAN
PHARMA
INDUSTRY
BY
K. V. SURYA SIVA KUMAR
2nd B PHARMACY
CHEBROLU HANUMAIAH INSTITUTE OF
PHARMACEUTICAL SCIENCES
CHOWDAVARAM, GUNTUR, A.P.

2. The Indian pharmaceutical industry has
become the third largest producer in the world and is
poised to grow into an industry of $20 billion in 2015 from
the current turnover of $12 billion.
Indian government had started to encourage the
growth of drug manufacturing by Indian
companies in 1960 and introduced a new act
PATIENT’S ACT in 1970.
India’s Biopharmaceutical industry clocked a
17% growth with Rs. 137 Billion in 2009-10.
Exports of Pharmaceuticals from India were increased from US$6.23 billion to US$8.7
billion in 2009.
• Now the Indian pharmaceutical industry had become the third largest producer in the
world and increased the turnover of US$20 billion in 2015
• The pharmaceutical industry in India meets around 70% of country’s demand for bulk
drugs, pharmaceutical dosage forms like tablets, capsules, orals and parentals etc…,

3. • Now the Indian pharma industry was valuated at US$42 billion in 2021.
• India was the largest generic medicine provider with all crude facilities with a share of 20%
exports across the globe.
• India is the largest Vaccine manufacturing in the World with the percentage of 50%ge was
shared from India to all over the World.
• Indian export meets the standards of Canada, US, UK, European Union etc…..,
• Indian pharma industry providing Generic medicines of a greater discounts at low costs.

4. THE INDIAN
PHARMACEUTICAL SECTOR IS
ESTIMATED TO ACCOUNT FOR
3.1-3.6% OF GLOBAL
PHARMACEUTICAL INDUSTRY
IN VALUE & 10% IN VOLUME.
INDIA ACCOUNTS 20% OF GLOBAL
EXPOTRS IN GENERICS. INDIA’S
PHARMACEUTICAL EXPORTS STOOD
AT US$16.84 BILLION IN 2016-17&
EXPECTED TO REACH US$20BILLION
BY 2020
LEADING
PHARMA
PRODUCER
ONE OF
THE
HIGHEST
EXPORTS

5. • BIOTECH
INDUSTRY
• HIGH
POTENTIAL
GENERICS
MARKET
• RAPIDLY
GROWING
HEALTH CARE
SECTOR
• AMONG THE
FASTEST
GROWING
INDUSTRIES
The country’s
pharmaceutical
industry is
expected to
expand at a CAGR
of 12.89% over
2015-2020 to
reach US$55
Billion
Indian health care
sector is one of
the fastest
growing sectors, is
expected at CAGR
of 17% to reach
US$ 250 billion
over 2008-2020
India has the
leading biotech
industry resource
as India supplied
COVID-19 vaccine
over to many
countries after
India’s vaccination
The generic
market stood
at US$26.1
billion in 2016
and estimated
to reach
US$50billion
by 2022.

6. EVOLUTION OF INDIAN PHARMACEUTICAL SECTOR
1970-90
INDIAN PATENT ACT passed
in 1970
Served domestic companies
start operations
Development of product
infrastructure
Export initiatives taken
1990-2010
Liberalized market
Indian companies
increasing launch in
foreign countries
Approval of Patent Act 2005
Major destination for
generic drug manufacturing
2010
Increased patent fillings by
pharma players
New sales models were
introduced
THE NATIONAL
PHARMACEUTICAL PRICING
POLICY 2012 was
introduced
2010-15
New drug pricing policy
issued in 2013
100% FDI allowed in
medical device industry in
2014
By 2015, India has 10500
manufacturing units & over
3000 pharma companies
2016 Onwards
In union budget, 2016, FDI
increased to 74% in existing
pharmaceutical companies
In 2020, The Indian
government unveiled
PHARMA VISION 2020
aimed making India a
global leader in end-to-end
drug manufacture

7. INDIAN PHARMA
GAINTS RAISE THEIR
R&D SPENDING
In the year 2017, highest
expenditure on research and
development has been done by
Sun Pharma, followed by Lupin
Sun Pharma’s R&D spending is
7.6% of total sales in the year
2017
Lupin’s R&D spending is 13.5% of
total sales in the year 2017
Then Dr. Rdeey’s, Cipla, Aurbindo,
Zydus Cadila, Wockhardt were
followed.

8. STATES HOSTING KEY PHARMACEUTICAL
VENTURES

9. INCREASE IN THE PRODUCTION OF PHARMACEUTICALS IN
INDIA
VAST INCREASE OF PRODUCTION FROM 2013-
2021
MANUFACTURING COST INDEX BY
COUNTRY
3rd LARGEST PRODUCTION COUNTRY ALL OVER THE
WORLD
A VAST INCREASE OF 103% OF PRODUCTION

10. DRIVERS OF INDIAN PHARMA
SECTOR

11. • India’s Pharma exports grow by 103% since 2013-14
• Pharma exports in 2021-22 sustain a positive growth among the global trade disruptions
• Pharma trade balance continues to be in India’s favour
• Around 55% of Indian pharma exports cater to highly regulated markets.
• The Indian pharma exports witnessed a growth from Rs. 90,415 Crores to Rs. 1.83.422 Crores
since 2013-14 to 2021-22.
• The growth with exports growing almost by US$10 billion in 8 years.
• INDIA is serving as THE PHARMACY OF THE WORLD.

12. LAYA
VSS